Management of cognitive and negative symptoms in schizophrenia
Mental Health Clinician · 01.10.2022 · 12 (5) · 282-299
DOI: 10.9740/mhc.2022.10.282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mental Health Clinician, online erschienen am 03.11.2022. Verfasst von Megan Maroney. Beteiligte Einrichtung: Clinical Associate Professor, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey; Clinical Psychiatric Pharmacist, Monmouth…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Currently available antipsychotics provide only modest benefit in managing the cognitive and negative symptoms of schizophrenia even though these symptoms are often the most impairing in patients' daily lives. Certain antipsychotics may have slight benefits over others, and several nonpharmacologic and pharmacologic adjunctive treatments have been evaluated in recent clinical trials. Recently published meta-analyses and clinical studies of such treatments are reviewed. Potential strategies to manage cognitive and negative symptoms, including deprescribing of medications that may exacerbate these symptoms, are described using theoretical case examples.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Associate Professor, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey; Clinical Psychiatric Pharmacist, Monmouth Medical Center, Long Branch, New Jersey, meganemaroney@gmail.com.
ORCID-Profile: Megan Maroney
Zitieren
APA
Maroney, M. (2022). Management of cognitive and negative symptoms in schizophrenia. Mental Health Clinician, 12(5), 282-299. https://doi.org/10.9740/mhc.2022.10.282
Vancouver
Maroney M. Management of cognitive and negative symptoms in schizophrenia. Mental Health Clinician. 2022;12(5):282-299. doi:10.9740/mhc.2022.10.282
BibTeX
@article{Maroney2022,
author = {Maroney, Megan},
title = {Management of cognitive and negative symptoms in schizophrenia},
journal = {Mental Health Clinician},
year = {2022},
volume = {12},
number = {5},
pages = {282--299},
doi = {10.9740/mhc.2022.10.282}
}
EUVIMED